0001497446-15-000001.txt : 20150115 0001497446-15-000001.hdr.sgml : 20150115 20150114175737 ACCESSION NUMBER: 0001497446-15-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150115 DATE AS OF CHANGE: 20150114 EFFECTIVENESS DATE: 20150115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GeneWeave Biosciences, Inc. CENTRAL INDEX KEY: 0001497446 IRS NUMBER: 272792087 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-219595 FILM NUMBER: 15528022 BUSINESS ADDRESS: STREET 1: 983 UNIVERSITY AVE., BUILDING B CITY: LOS GATOS STATE: CA ZIP: 95032 BUSINESS PHONE: 408 560-9200 MAIL ADDRESS: STREET 1: 983 UNIVERSITY AVE., BUILDING B CITY: LOS GATOS STATE: CA ZIP: 95032 D/A 1 primary_doc.xml X0707 D/A LIVE 0001497446 GeneWeave Biosciences, Inc. 983 UNIVERSITY AVE., BUILDING B LOS GATOS CA CALIFORNIA 95032 408 560-9200 DELAWARE None None Corporation true 2010 Steven Tablak c/o GeneWeave Biosciences, Inc. 983 University Ave., Building B Los Gatos CA CALIFORNIA 95032 Executive Officer Director Nora Bianchi c/o GeneWeave Biosciences, Inc. 983 University Ave., Building B Los Gatos CA CALIFORNIA 95032 Executive Officer Jason Springs c/o GeneWeave Biosciences, Inc. 983 University Ave., Building B Los Gatos CA CALIFORNIA 95032 Executive Officer Director Diego Rey c/o GeneWeave Biosciences, Inc. 983 University Ave., Building B Los Gatos CA CALIFORNIA 95032 Executive Officer Werner Frei c/o GeneWeave Biosciences, Inc. 983 University Ave., Building B Los Gatos CA CALIFORNIA 95032 Executive Officer Kenneth Bahk, Ph.D. c/o GeneWeave Biosciences, Inc. 983 University Ave., Building B Los Gatos CA CALIFORNIA 95032 Director Min Cui, Ph.D. c/o GeneWeave Biosciences, Inc. 983 University Ave., Building B Los Gatos CA CALIFORNIA 95032 Director Ted Driscoll, Ph.D. c/o GeneWeave Biosciences, Inc. 983 University Ave., Building B Los Gatos CA CALIFORNIA 95032 Director Biotechnology Decline to Disclose 06b true 0001497446-14-000003 2014-05-23 false true true true true Offering of Series B Preferred Stock ("Series B"), warrant to purchase Series B ("Warrant"), the underlying shares of Series B issuable upon exercise of Warrant and the underlying shares of Common Stock issuable upon conversion of Series B. false 0 12400002 12200000 200002 false 5 0 0 0 false GeneWeave Biosciences, Inc. /s/ Nora Bianchi Nora Bianchi Chief Financial Officer 2015-01-12